Synaptogenix Stock Fundamentals
| SNPX Stock | USD 4.56 0.01 0.22% |
Synaptogenix fundamentals help investors to digest information that contributes to Synaptogenix's financial success or failures. It also enables traders to predict the movement of Synaptogenix Stock. The fundamental analysis module provides a way to measure Synaptogenix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Synaptogenix stock.
At this time, Synaptogenix's Net Interest Income is fairly stable compared to the past year. Interest Income is likely to rise to about 1.6 M in 2024, whereas Depreciation And Amortization is likely to drop 5,782 in 2024. Synaptogenix | Select Account or Indicator |
Synaptogenix Company Return On Equity Analysis
Synaptogenix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Synaptogenix Return On Equity | -0.2 |
Most of Synaptogenix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Synaptogenix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Synaptogenix Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Synaptogenix has a Return On Equity of -0.198. This is 99.17% lower than that of the Biotechnology sector and 99.46% lower than that of the Health Care industry. The return on equity for all United States stocks is 36.13% lower than that of the firm.
Synaptogenix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Synaptogenix's current stock value. Our valuation model uses many indicators to compare Synaptogenix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Synaptogenix competition to find correlations between indicators driving Synaptogenix's intrinsic value. More Info.Synaptogenix is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . At this time, Synaptogenix's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Synaptogenix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Synaptogenix's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Synaptogenix's earnings, one of the primary drivers of an investment's value.Synaptogenix Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Synaptogenix's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Synaptogenix could also be used in its relative valuation, which is a method of valuing Synaptogenix by comparing valuation metrics of similar companies.Synaptogenix is currently under evaluation in return on equity category among related companies.
Synaptogenix Fundamentals
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | (23.9 M) | ||||
| Shares Outstanding | 1.09 M | ||||
| Shares Owned By Insiders | 2.43 % | ||||
| Shares Owned By Institutions | 3.92 % | ||||
| Number Of Shares Shorted | 298.54 K | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.31 M) | ||||
| Net Income | (6.04 M) | ||||
| Cash And Equivalents | 28.75 M | ||||
| Cash Per Share | 4.20 X | ||||
| Current Ratio | 47.22 X | ||||
| Book Value Per Share | 25.27 X | ||||
| Cash Flow From Operations | (5.17 M) | ||||
| Short Ratio | 0.67 X | ||||
| Earnings Per Share | (29.50) X | ||||
| Target Price | 14.0 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 4.96 M | ||||
| Total Asset | 31.11 M | ||||
| Retained Earnings | (33.61 M) | ||||
| Working Capital | 26.26 M | ||||
| Net Asset | 31.11 M |
About Synaptogenix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synaptogenix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synaptogenix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synaptogenix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 0.00 | 0.00 | |
| Cost Of Revenue | 6.3 K | 5.8 K | |
| Stock Based Compensation To Revenue | 0.00 | 0.00 | |
| Sales General And Administrative To Revenue | 0.00 | 0.00 | |
| Research And Ddevelopement To Revenue | 0.00 | 0.00 | |
| Capex To Revenue | 0.00 | 0.00 | |
| Revenue Per Share | 0.00 | 0.00 | |
| Ebit Per Revenue | 0.00 | 0.00 |
Currently Active Assets on Macroaxis
When determining whether Synaptogenix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synaptogenix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synaptogenix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synaptogenix Stock:Check out Synaptogenix Piotroski F Score and Synaptogenix Altman Z Score analysis. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Synaptogenix Stock analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Synaptogenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synaptogenix. If investors know Synaptogenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synaptogenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.50) | Return On Assets (0.15) | Return On Equity (0.20) |
The market value of Synaptogenix is measured differently than its book value, which is the value of Synaptogenix that is recorded on the company's balance sheet. Investors also form their own opinion of Synaptogenix's value that differs from its market value or its book value, called intrinsic value, which is Synaptogenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synaptogenix's market value can be influenced by many factors that don't directly affect Synaptogenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synaptogenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Synaptogenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synaptogenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.